Company profile
BioCardia, Inc.
NASDAQ:BCDABiotechnology: Biological Products (No Diagnostic Substances)
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05491681 | phase1 | withdrawn | 2026-01-04 | 2026-01-04 | BioCardia, Inc. | AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial |
| NCT02438306 | phase3 | completed | 2016-12-01 | 2025-02-01 | BioCardia, Inc. | CardiAMP™ Cell Therapy for Heart Failure Trial |
FDA applications (0)
No records yet.